GeneNews Closes CDN $510,000 Second Tranche of Strategic Private Placement
TORONTO, ON / ACCESSWIRE / April 2, 2019 / GeneNews Limited (TSX: GEN) ("GeneNews" or the "Company") today announced that...
TORONTO, ON / ACCESSWIRE / April 2, 2019 / GeneNews Limited (TSX: GEN) ("GeneNews" or the "Company") today announced that...
Panel presentation will provide an overview and outlook on BackBeat Cardiac Neuromodulation Therapy, a potent, novel bioelectronic treatment for hypertension...
TORONTO, ON / ACCESSWIRE / April 2, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Announces that is has signed...
Animal Study Demonstrates Combination of HS-110 and HS-130 Yields Three-Fold Increase in Anti-Tumor CD8+ T-cell Expansion DURHAM, NC / ACCESSWIRE...
AUSTIN, TX / ACCESSWIRE / April 2, 2019 / Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced...
Reports on Commercial Progress for both PainShield® and UroShield® ELMSFORD, NY / ACCESSWIRE / April 2, 2019 / NanoVibronix, Inc.,...
SAN DIEGO, CA / ACCESSWIRE / April 2, 2019 / Dthera™ Sciences (OTCQB: DTHR) a leading digital therapeutic company specializing...
LIVINGSTON, NJ / ACCESSWIRE / April 2, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized...
Results of Phase Ib Non-Muscle Invasive Bladder Cancer ("NMIBC") Clinical Study Demonstrate a 66% Complete Response ("CR") at the Therapeutic...
April 2, 2019 – Genmed, a specialist provider of vendor neutral managed services to the NHS, today announces the appointment...
BridgeHead’s Independent Clinical Archive will now house all medical images across the TrustASHTEAD, UK – 2 April 2019 – As...
SAN FRANSISCO, CA / ACCESSWIRE / April 2, 2019 / Napo Pharmaceuticals, Inc. (Napo), a human health company developing and...
PLANEGG/MUNICH GERMANY / ACCESSWIRE / April 1, 2019 / Dr. Sarah Fakih joined MorphoSys AG (FSE: MOR; Prime Standard Segment,...
NEW YORK, NY / ACCESSWIRE / April 1, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Arthur Kirsch...
SAN CLEMENTE, CA / ACCESSWIRE / April 1, 2019 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive...
The NHS England diabetes team has partnered with Oxford Medical Simulation to train doctors using virtual reality. Doctors can now...
PH94B has potential to be the First FDA-Approved PRN Treatment for Social Anxiety Disorder New Findings Presented at the 2019...
CALGARY, AB / ACCESSWIRE / April 1, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (OTC...
SAN CLEMENTE, CA / ACCESSWIRE / April 1, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
AUSTIN, TX / ACCESSWIRE / April 1, 2019 / Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced...